| Affymax and Takeda Announce Preliminary U.S. Registration Strategy for ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Subject to feedback from the FDA, the plan is to pursue a New Drug Application (NDA) for treatment of anemia in dialysis patients, while continuing to ... read more |